Research programme: conjugated monoclonal antibodies - Cytune Pharma

Drug Profile

Research programme: conjugated monoclonal antibodies - Cytune Pharma

Alternative Names: ICKs; Immunocytokines - Cytune Pharma

Latest Information Update: 21 Jan 2014

Price : $50

At a glance

  • Originator Cytune Pharma
  • Class Drug conjugates; Immunoconjugates; Monoclonal antibodies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Research Cancer

Most Recent Events

  • 21 Jan 2014 Early research in Cancer in France (Parenteral)
  • 21 Jan 2014 Research programme: conjugated monoclonal antibodies - Cytune Pharma is available for licensing as of 21 Jan 2014. http://www.cytunepharma.com/
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top